Has Anne Callahan received payments from drug or device companies?

Yes. Drug and device makers reported $30,401 in general payments to Anne Callahan across 228 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anne Callahan did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anne Callahan come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anne Callahan

Medical · San Ramon, CANPI 1891082483

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $20,052 of the $30,401 with a category attached, or 66.0%. 23 manufacturers reported payments, led by Sanofi at 52.8% of the total. Reporting peaked in 2023 at $15,376 and has fallen 97.9% since, to $316 in 2025. Among medical clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$30,401in general payments, 2019–2025

Across 228 payments — averaging $133.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$16K
Regeneron Healthcare Solutions, Inc.$11K
AbbVie$976
Incyte Corporation$568
Almirall LLC$274
Revance Therapeutics, Inc.$255
plus $2K from 17 others

What the payments were for

Consulting fees$2,0167%
Speaking & faculty fees$20,05266%
Travel & lodging$2,1337%
Food & beverage$5,98520%
Education$2151%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	60	$16,046
Regeneron Healthcare Solutions, Inc.	40	$10,529
AbbVie	42	$976
Incyte Corporation	16	$568
Almirall LLC	11	$274
Revance Therapeutics, Inc.	4	$255
Johnson & Johnson	8	$208
Galderma Laboratories, L.p.	5	$171
Regeneron	2	$155
Amgen	2	$144
Sun Pharmaceutical Industries Inc.	2	$134
Pfizer	6	$128
Sanofi-aventis U.S. LLC	1	$112
Ortho Dermatologics, A Division Of Bausch Health US, LLC	3	$112
LEO Pharma Inc.	5	$105
Lilly USA, LLC	4	$103
E.r. Squibb & Sons, L.L.C.	4	$87
Arcutis Biotherapeutics, Inc.	4	$83
Mayne Pharma Commercial LLC	3	$61
Dermavant Sciences, Inc.	2	$54
Novartis	2	$39
Janssen Scientific Affairs, LLC	1	$31
EPI Health, LLC	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$39,158
OPZELURA$242
Otezla$110
DAXXIFY$110

How this compares

$30,401 in reported general payments places this provider in the 95th percentile of 2,087 medical providers in California.

See all medical providers in California →

Other medical in San Ramon

Nicola LowreyOrange$655K
Justin LoveLoma Linda$553K
Alison GracomIrvine$467K
Jeffrey BonnaudLos Angeles$314K
Ana TorresLaguna Beach$229K
Heather ParlettRedlands$168K
David DoriguzziLancaster$166K
Deirdre MoxleyFullerton$149K
Linda RankLadera Ranch$105K
Cheryl KyinnSan Diego$103K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →